NCT00866723View on ClinicalTrials.gov

Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

June 30, 2012

Conditions
Ovarian CancerPrimary Peritoneal Serous CancerFallopian Tube Cancer
Interventions
DRUG

bevacizumab

Trial Locations (3)

02114

Massachusetts General Hospital, Boston

02115

Dana-Farber Cancer Institute, Boston

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

Genentech, Inc.

INDUSTRY

lead

Beth Israel Deaconess Medical Center

OTHER